Scarica l'app Stockscreener
521.63
1.01%
-4.44
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$526.07
Aprire:
$522.69
Volume 24 ore:
379.99K
Relative Volume:
0.24
Capitalizzazione di mercato:
$198.17B
Reddito:
$42.37B
Utile/perdita netta:
$6.14B
Rapporto P/E:
34.18
EPS:
15.26
Flusso di cassa netto:
$7.78B
1 W Prestazione:
-0.86%
1M Prestazione:
-1.67%
6M Prestazione:
-5.83%
1 anno Prestazione:
-1.89%
Intervallo 1D:
$515.77
$522.93
Intervallo di 1 settimana:
$515.77
$528.98
Portata 52W:
$493.30
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Confronta TMO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
521.77 | 198.17B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
229.97 | 164.46B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
134.81 | 38.07B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.61 | 35.46B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
412.16 | 33.34B | 3.84B | 866.24M | 792.60M | 10.37 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Jim Cramer on Thermo Fisher Scientific Inc. (TMO): ‘I Think Things Will Gradually Improve For Thermo Fisher With Business Picking Up In 2025 and 2026’ - Yahoo Finance
Thermo Fisher Scientific Increases Quarterly Dividend payable on April 16, 2020 - BioSpace
8 Stocks on Jim Cramer’s Radar - Insider Monkey
Thermo Fisher Scientific Inc. stock outperforms market despite losses on the day - MarketWatch
Crispr Market Detailed In New Research Report 2024 | Thermo - openPR
Proteomics Market Key Players AnalysisThermo Fisher - openPR
Thermo Fisher Scientific Inc. stock falls Thursday, underperforms market - MarketWatch
RPMI Media Market Key Players AnalysisMerck KGaA, Thermo - openPR
Thermo Fisher Scientific Inc: An Exploration into Its Intrinsic Value - Yahoo Finance
Thermo Fisher Scientific Inc. stock rises Tuesday, still underperforms market - MarketWatch
Pharmaceuticals & Medicine Manufacturing Market Set to Surge at 8.9% CAGR, to Reach US$ 2,516.46 Million by 2034 | Fact.MR Report - GlobeNewswire Inc.
Legionella Testing Market Key Players AnalysisThermo Fisher - openPR
Predictive Biomarkers Market Top Companies StudyThermo - openPR
Scotiabank Initiates Coverage of Thermo Fisher Scientific (TMO) with Sector Perform Recommendation - MSN
Thermo Fisher Scientific Inc. stock rises Monday, still underperforms market - MarketWatch
This Omeros Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Pony AI, Thermo Fisher initiated: Wall Street's top analyst calls - Yahoo Finance
Thermo Fisher Scientific (NYSE:TMO) Earns Sector Perform Rating from Analysts at Scotiabank - MarketBeat
Immuno-Oncology Assays Market Future Business Opportunities - openPR
Recombinant Human (EGF) Market Is Booming Worldwide 2024-2031 | - openPR
Jim Cramer Reports That Thermo Fisher Scientific Inc. (TMO)’s China Sales Were Flat Year-Over-Year In The Nine Months Ending In September - Yahoo Finance
M&T Bank Corp Has $70.11 Million Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Primary Cells Market Key Players AnalysisThermo Fisher - openPR
Allergy Diagnostic Market New Product Development & Latest Trends | Thermo Fisher Scientific, PerkinElmer, Danaher - openPR
Gamma Ray Spectroscopy Market Is Booming Worldwide 2024-2031 | - openPR
mRNA Extraction and Purification Market Top PlayersQiagen, - openPR
Focused Ion Beam Market to Set Phenomenal Growth From 2024 to 2032 | Thermo Fisher Scientific, Tescan, JEOL - openPR
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Knipper Health Announces Transfer of Commercial Sample Management Business from Thermo Fisher Scientific - Business Wire
Thermo Fisher (TMO) Stock Is Ready For Breakout, Here’s Why - Insider Monkey
Thermo Fisher Scientific's SWOT analysis: stock outlook amid market shifts - Investing.com
Thermo Fisher Scientific Inc. stock falls Tuesday, still outperforms market - MarketWatch
Next Generation Sequencing Market Size, Share & Growth Forecast with CAGR 14.5% by 2031 | Thermo Fisher - EIN News
Research Antibodies Market to See Booming Growth 2024-2031 | - openPR
Clinical Oncology Next Generation Sequencing Market Top - openPR
Brain Cancer Diagnostics Market Top Companies StudyThermo - openPR
Plant Tissue Culture Market Detailed In New Research Report 2024 - openPR
Tumor Microenvironment Market Key Players AnalysisThermo - openPR
FCO clears Olink’s acquisition by Thermo Fisher following in-depth review - Cleary Antitrust Watch
Thermo Fisher Scientific Inc. stock rises Monday, outperforms market - MarketWatch
Scanfil Suzhou Factory Receives Sustainability Award from Thermo Fisher Scientific - I-Connect007
Neglected Tropical Disease Treatment Market Key Players - openPR
Gene Panel Market CAGR of 20.2% Trends, Shares and Demand Analysis By 2024 To 2031 | Thermo Fisher Scientific - EIN News
The Zacks Analyst Blog Highlights Visa, Linde, Thermo Fisher Scientific, Tile Shop and Autoscope - Yahoo Finance
Leerink Partnrs Issues Pessimistic Forecast for TMO Earnings - MarketBeat
Thermo Fisher Scientific Says FDA Cleared Its Biomarkers for Pregnancy Complication - Marketscreener.com
1,032 Shares in Thermo Fisher Scientific Inc. (NYSE:TMO) Bought by Virtu Financial LLC - MarketBeat
Lord Abbett & CO. LLC Sells 2,758 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific (NYSE:TMO) Price Target Cut to $660.00 by Analysts at Bank of America - MarketBeat
Thermo Fisher Scientific to Acquire CorEvitas For $912.5 Million in Cash - Marketscreener.com
Top Analyst Reports for Visa, Linde & Thermo Fisher Scientific - Yahoo Finance
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):